Apelin-13 vs Elabela — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Apelin-13 is the most biologically active isoform of the apelin peptide family, endogenous ligands for the APJ receptor (also called APLNR). Apelin peptides are produced throughout the body, with the heart, lung, brain, and adipose tissue expressing particularly high levels....
Calculate Apelin-13 dose →Elabela (also called Apela or Toddler) is the second endogenous peptide ligand for the APJ receptor, discovered in 2013 independently through two approaches: as an essential zebrafish cardiac development factor (Toddler) and as a novel human APJ ligand (Elabela). Unlike apelin pe...
Calculate Elabela dose →| Parameter | Apelin-13 | Elabela |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Clinical | Research |
| Half-Life | < 5 min (plasma) | Short (minutes, estimated) |
| Typical Dose | 50-300 nmol/kg | 5-500 nmol/kg (animal) |
| Frequency | Variable | Variable |
| Route | Intravenous (research), Subcutaneous | Subcutaneous, Intravenous |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.